Improved Mass Spectrometric Method Presented for Proteomic Analyses
By LabMedica International staff writers Posted on 25 Mar 2014 |
Image: The NanoACQUITY Ultra Performance Liquid Chromatograph (Photo courtesy of Waters Corporation).
Mass spectrometry is a highly sensitive method of measurement of cell components or body fluids that has been used for the analysis of chemical and biological materials.
A proteome represents the entire set of proteins expressed by a cell and through analysis of proteomes, it is possible to obtain a comprehensive picture of the proteins and peptides present in cells or body fluids.
Scientists at the Johannes Gutenberg University (Mainz, Germany) have optimized the mass spectrometric workflow which allows the identification and significantly quantifies more proteins than before. They have perfected a relatively new, data-independent technique that facilitates a very accurate and reproducible quantitative analysis. The team focused in particular on developing novel techniques for quantitative proteomic analysis with the aid of so-called ion mobility mass spectrometry. This technique allows not only measuring the mass of a molecule but can also determine its cross section.
The investigators have also managed to enhance the technique known as label-free quantification. This eliminates the need for samples to be labeled in the laboratory before being analyzed, an otherwise complex procedure. Liquid chromatography-ion mobility separation-mass spectrometry (LC-IMS-MS) was performed using HeLa cell lysates. A software program for the integrated analysis of measurement data called ISOQuant has also been developed. This additional analytical dimension renders the technique optimally suited for the comprehensive investigation of highly complex samples.
Nanoscale separation of tryptic peptides was performed with a nanoACQUITY Ultra Performance Liquid Chromatography (UPLC) system (Waters Corporation, Milford, MA, USA) and mass spectrometric analysis of tryptic peptides was performed using a Synapt G2-S HDMS mass spectrometer, also from Waters Corporation. The average intensity of three most intense peptides strongly correlates with the absolute amount of their source protein. ISOQuant implements the quantification method, and additionally allows user-defined approaches, varying the number of peptides used for protein quantification.
Stefan Tenzer, PhD, an immunologist and the lead author of the study said, “We are now able to directly analyze patient samples and specific immune cells without prior cost-intensive preparation.” His colleagues added that the years of work within the technology platform have paid off in terms of a quantum leap forward with regard to the improvement of the technique of proteomic analysis mass spectrometry. The study was published in the March 2014 edition of the journal Nature Methods.
Related Links:
Johannes Gutenberg University
Waters Corporation
A proteome represents the entire set of proteins expressed by a cell and through analysis of proteomes, it is possible to obtain a comprehensive picture of the proteins and peptides present in cells or body fluids.
Scientists at the Johannes Gutenberg University (Mainz, Germany) have optimized the mass spectrometric workflow which allows the identification and significantly quantifies more proteins than before. They have perfected a relatively new, data-independent technique that facilitates a very accurate and reproducible quantitative analysis. The team focused in particular on developing novel techniques for quantitative proteomic analysis with the aid of so-called ion mobility mass spectrometry. This technique allows not only measuring the mass of a molecule but can also determine its cross section.
The investigators have also managed to enhance the technique known as label-free quantification. This eliminates the need for samples to be labeled in the laboratory before being analyzed, an otherwise complex procedure. Liquid chromatography-ion mobility separation-mass spectrometry (LC-IMS-MS) was performed using HeLa cell lysates. A software program for the integrated analysis of measurement data called ISOQuant has also been developed. This additional analytical dimension renders the technique optimally suited for the comprehensive investigation of highly complex samples.
Nanoscale separation of tryptic peptides was performed with a nanoACQUITY Ultra Performance Liquid Chromatography (UPLC) system (Waters Corporation, Milford, MA, USA) and mass spectrometric analysis of tryptic peptides was performed using a Synapt G2-S HDMS mass spectrometer, also from Waters Corporation. The average intensity of three most intense peptides strongly correlates with the absolute amount of their source protein. ISOQuant implements the quantification method, and additionally allows user-defined approaches, varying the number of peptides used for protein quantification.
Stefan Tenzer, PhD, an immunologist and the lead author of the study said, “We are now able to directly analyze patient samples and specific immune cells without prior cost-intensive preparation.” His colleagues added that the years of work within the technology platform have paid off in terms of a quantum leap forward with regard to the improvement of the technique of proteomic analysis mass spectrometry. The study was published in the March 2014 edition of the journal Nature Methods.
Related Links:
Johannes Gutenberg University
Waters Corporation
Latest Immunology News
- Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies
- AI Tool Precisely Matches Cancer Drugs to Patients Using Information from Each Tumor Cell
- Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment
- Testing Method Could Help More Patients Receive Right Cancer Treatment
- Groundbreaking Test Monitors Radiation Therapy Toxicity in Cancer Patients
- State-Of-The Art Techniques to Investigate Immune Response in Deadly Strep A Infections
- Novel Immunoassays Enable Early Diagnosis of Antiphospholipid Syndrome
- New Test Could Predict Immunotherapy Success for Broader Range Of Cancers
- Simple Blood Protein Tests Predict CAR T Outcomes for Lymphoma Patients
- Cell Sorter Chip Technology to Pave Way for Immune Profiling at POC
- Chip Monitors Cancer Cells in Blood Samples to Assess Treatment Effectiveness
- Automated Immunohematology Approaches Can Resolve Transplant Incompatibility
- AI Leverages Tumor Genetics to Predict Patient Response to Chemotherapy
- World’s First Portable, Non-Invasive WBC Monitoring Device to Eliminate Need for Blood Draw
- Predictive T-Cell Test Detects Immune Response to Viruses Even Before Antibodies Form
- Single Blood Draw to Detect Immune Cells Present Months before Flu Infection Can Predict Symptoms